Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics

BACKGROUND: Widespread ceftriaxone antimicrobial resistance (AMR) threatens Neisseria gonorrhoeae (NG) treatment, with few alternatives available. AMR point-of-care tests (AMR POCT) may enable alternative treatments, including abandoned regimens, sparing ceftriaxone use. We assessed cost-effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding-Esch, Emma M, Huntington, Susie E, Harvey, Michael J, Weston, Georgie, Broad, Claire E, Adams, Elisabeth J, Sadiq, S Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596918/
https://www.ncbi.nlm.nih.gov/pubmed/33124553
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.43.1900402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596918/
https://www.ncbi.nlm.nih.gov/pubmed/33124553
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.43.1900402

Ejemplares similares